Third Arc Bio
Debi Watson serves as the Chief Business Officer at Third Arc Bio. Prior experience includes significant roles at Johnson & Johnson, where Debi held the positions of Vice President for Venture Investments at JJDC, Vice President of Janssen Business Development in Oncology, and Vice President of Licensing & Business Development in Infectious Disease.
This person is not in any teams
Third Arc Bio
Third Arc Bio is a biotech company developing multifunctional antibodies that generate immune synapses that precisely activate or inhibit T cells. The company’s drug development engine delivers superior biologics optimized to create best-in-class T cell engagement by leveraging two technologies that power a pipeline of high value therapeutics – a solid tumor synergy platform and an I&I platform that offers a novel approach to precision immune regulation at a tissue-specific level to achieve superior efficacy and safety. To learn more, visit www.thirdarcbio.com.